De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation.

被引：0
|
作者：
Petrossian, G. [1 ]
Ortiz, J. [2 ]
Addonizio, K. [1 ]
Hsiao, A. [1 ]
Teixeira, L. [1 ]
Koizumi, N. [3 ]
James, R. [3 ]
Patel, S. [4 ]
Conti, D. [2 ]
Plews, R. [2 ]
机构：
[1] Albany Med Ctr, Albany, NY USA
[2] Albany Med Ctr, Div Renal & Pancreat Transplant Serv, Albany, NY USA
[3] George Mason Univ, Fairfax, VA 22030 USA
[4] UMC Las Vegas, Las Vegas, NV USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
413
引用
收藏
页码：512 / 512
页数：1
相关论文
共 50 条
  • [1] Proteinuria is Associated with Increased Risk for Cardiovascular Disease after Kidney Transplantation.
    Rahamimov, R.
    Molcho, M.
    Vahav, I.
    Chagnac, A.
    Mor, E.
    Rozen-Zvi, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 542 - 542
  • [2] Incidence and prognosis of de-novo malignancies after liver transplantation.
    Graziadei, IW
    Nachbaur, K
    Koenigsrainer, A
    Margreiter, R
    Vogel, W
    HEPATOLOGY, 2003, 38 (04) : 256A - 256A
  • [3] De-Novo Belatacept Therapy is Associated with Higher Levels of BK Viremia and Lower Rates of BK Clearance in Kidney Transplantation Patients.
    Petrossian, G.
    Ortiz, J.
    Addonizio, K.
    Teixeira, L.
    Hsiao, A.
    James, R.
    Koizumi, N.
    Patel, S.
    Conti, D.
    Plews, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1089 - 1089
  • [4] De novo congestive heart failure after kidney transplantation.
    Lentine, KL
    Schnitzler, MA
    Abbott, KC
    Li, L
    Burroughs, TE
    Irish, W
    Brennan, DC
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 555 - 555
  • [5] The Natural History of De Novo DSA After Kidney Transplantation.
    Lopez del Moral, C.
    Lachmann, N.
    Hergovits, S.
    Stauch, D.
    Akifova, A.
    Naik, M.
    Osmanodja, B.
    Schmidt, D.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 959 - 960
  • [6] Long-Term Follow-Up and Risk Factors Associated with "De-Novo" Tumors after Adult Liver Transplantation.
    Sapisochin, Gonzalo
    Bilbao, Itxarone
    Landi, Filippo
    Dopazo, Cristina
    Castells, Luis
    Rodriguez, Roberto
    Campos-Varela, Isabel
    Luis Lazaro, Jose
    Torres, Mireia
    Caralt, Mireia
    Charco, Ramon
    LIVER TRANSPLANTATION, 2012, 18 : S207 - S207
  • [7] The underlying disease influences the risk for CMV infection and CMV disease after liver transplantation.
    Bonatti, H
    Kafka, R
    Muehlmann, G
    Larcher, C
    Ladurner, R
    Laesser, R
    Margreiter, R
    Graziadei, I
    HEPATOLOGY, 2000, 32 (04) : 604A - 604A
  • [8] De-Novo IBD After Kidney Transplant: Use of Vedolizumab Therapy
    Modi, Zeel N.
    Trivedi, Itishree
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2153 - S2153
  • [9] Risk Factors of De Novo Malignancies after Liver Transplantation.
    Altieri, M.
    Seree, O.
    Dumortier, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 725 - 725
  • [10] Clinical Evolution of Patients with De Novo DSA After Kidney Transplantation.
    Lopez del Moral, C.
    Lachmann, N.
    Hergovits, S.
    Stauch, D.
    Akifova, A.
    Naik, M.
    Osmanodja, B.
    Schmidt, D.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 384 - 384
12345